A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM).

Gaetano GalloR PietrolettiE NovelliA SturialeR TutinoP LobascioR LaforgiaE MoggiaM PozzoM RoveroniV BiancoA Realis LucA GiulianiE DiacoG NaldiniM TrompettoR PerinottiG Sammarco

Published in: Techniques in coloproctology (2022)

Sclerotherapy with 3% polidocanol foam is a safe, effective, painless, repeatable and low-cost procedure in patients with bleeding haemorrhoids.

Keyphrases

low cost
open label
clinical trial
study protocol
phase ii
phase iii
phase ii study
atrial fibrillation
randomized controlled trial
double blind
cross sectional
placebo controlled
radiation therapy